NASDAQ:PETS PetMed Express (PETS) Stock Price, News & Analysis $1.56 +0.01 (+0.32%) As of 03:47 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About PetMed Express Stock (NASDAQ:PETS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PetMed Express alerts:Sign Up Key Stats Today's Range$1.55▼$1.5750-Day Range$1.55▼$2.0552-Week Range$1.55▼$4.10Volume68,756 shsAverage Volume308,671 shsMarket Capitalization$33.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview PetMed Express, Inc., doing business as PetMeds, is a direct-to-consumer pet pharmacy and online retailer. The company sells prescription and nonprescription medications, flea and tick treatments, vitamins and supplements, prescription diets, and other health products for dogs, cats, and other companion animals. PetMeds offers products through its website and other direct-order channels, providing pet owners with access to medications and supplies that may be recommended or prescribed by veterinarians. Its business model is focused on convenience, home delivery, and recurring purchases for ongoing pet-health needs. Founded in 1996, PetMed Express is headquartered in Delray Beach, Florida, and primarily serves customers in the United States. The company operates under the PetMeds and 1-800-PetMeds brands and is traded on the Nasdaq under the symbol PETS.AI Generated. May Contain Errors. Read More PetMed Express Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks21st Percentile Overall ScorePETS MarketRank™: PetMed Express scored higher than 21% of companies evaluated by MarketBeat, and ranked 415th out of 474 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingPetMed Express has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoveragePetMed Express has only been the subject of 1 research reports in the past 90 days.Read more about PetMed Express' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth28.57% Earnings GrowthEarnings for PetMed Express are expected to grow by 28.57% in the coming year, from $0.07 to $0.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PetMed Express is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PetMed Express is -1.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPetMed Express has a P/B Ratio of 1.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about PetMed Express' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.03% of the float of PetMed Express has been sold short.Short Interest Ratio / Days to CoverPetMed Express has a short interest ratio ("days to cover") of 7.68.Change versus previous monthShort interest in PetMed Express has recently increased by 12.33%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldPetMed Express does not currently pay a dividend.Dividend GrowthPetMed Express does not have a long track record of dividend growth.Dividend SustainabilityBased on EPS estimates, PetMed Express will have a dividend payout ratio of 1,000.00% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend.Read more about PetMed Express' dividend. News and Social Media2.0 / 5News Sentiment0.15 News SentimentPetMed Express has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Consumer Discretionary companies.News Coverage This WeekMarketBeat has tracked 5 news articles for PetMed Express this week, compared to 2 articles on an average week. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PetMed Express insiders have not sold or bought any company stock.Percentage Held by Insiders1.30% of the stock of PetMed Express is held by insiders.Percentage Held by Institutions73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PetMed Express' insider trading history. Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PETS Stock News HeadlinesAnalysts Conflicted on These Healthcare Names: Petmed Express (PETS) and Accendra Health (ACH)September 22 at 12:49 PM | theglobeandmail.comPetMeds Appoints Tamar Elkeles As Independent DirectorSeptember 22 at 7:48 AM | rttnews.comMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.September 24 at 1:00 AM | Paradigm Press (Ad)PetMed Express, Inc. Announces Appointment of Tamar Elkeles as Director, Effective September 17, 2026September 21 at 4:46 PM | marketscreener.comMPetMed Express adds human capital expert to boardSeptember 21 at 9:11 AM | tipranks.comPetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent DirectorSeptember 21 at 8:30 AM | globenewswire.comPetMed Express names fourth CEO in two years as leadership turnover continuesSeptember 17, 2026 | bizjournals.comPetMed Express, Inc. Announces CEO ChangesSeptember 17, 2026 | marketscreener.comMSee More Headlines PETS Stock Analysis - Frequently Asked Questions How have PETS shares performed this year? PetMed Express' stock was trading at $3.20 on January 1st, 2026. Since then, PETS stock has decreased by 51.4% and is now trading at $1.5550. How were PetMed Express' earnings last quarter? PetMed Express, Inc. (NASDAQ:PETS) announced its quarterly earnings data on Thursday, August, 13th. The company reported ($0.28) earnings per share for the quarter, missing the consensus estimate of $0.12 by $0.40. The company had revenue of $41.02 million for the quarter, compared to analysts' expectations of $71 million. PetMed Express had a negative net margin of 17.34% and a negative trailing twelve-month return on equity of 91.69%. Read the conference call transcript. Who are PetMed Express' major shareholders? Top institutional investors of PetMed Express include BlackRock Inc. (2.66%), Empowered Funds LLC (0.39%), Susquehanna International Group LLP (0.22%) and IMC Chicago LLC (0.11%). Insiders that own company stock include Silvercape Investments Ltd, Nina Capital Holdings Inc, Mathew N Hulett, Sandra Yvette Campos, Gian Fulgoni, Leslie CG Campbell, Jacqueline Paula Smith and Christine Chambers. View institutional ownership trends. How do I buy shares of PetMed Express? Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PetMed Express own? Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Meta Platforms (META), NVIDIA (NVDA), Intel (INTC), Pfizer (PFE), Walt Disney (DIS), Ford Motor (F) and PayPal (PYPL). Company Calendar Last Earnings8/13/2026Today9/24/2026Next Earnings (Estimated)10/13/2026Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (5m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 PETS's financial health is in the Red zone, according to TradeSmith. PETS has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Discretionary Industry Specialty Retail Sub-IndustryOther Specialty Retail Current SymbolNASDAQ:PETS CIK1040130 Webwww.petmeds.com Phone(561) 426-4444Fax561-526-4445Employees189Year Founded1996Profitability EPS (Trailing Twelve Months)($1.38) Trailing P/E RatioN/A Forward P/E Ratio22.21 P/E GrowthN/ANet Income-$57.29 million Net Margins-17.34% Pretax Margin-17.38% Return on Equity-91.69% Return on Assets-35.15% Debt Debt-to-Equity RatioN/A Current Ratio0.68 Quick Ratio0.47 Sales & Book Value Annual Sales$168.86 million Price / Sales0.20 Cash Flow$0.31 per share Price / Cash Flow5.08 Book Value$1.35 per share Price / Book1.15Miscellaneous Outstanding Shares21,679,000Free Float21,397,000Market Cap$33.71 million OptionableOptionable Beta0.78 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:PETS) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredOn October 7th, your “safest” assets are at riskJeff Brown called Nvidia's rise of over 27,000 percent and warned in early 2024 that inflation would outlast W...Brownstone Research | SponsoredArizona Gold Explorer Nears First-Ever Resource EstimateA little-known Arizona gold explorer just hit 66.2 metres grading 6.57 g/t gold, including 20.7 metres at 18.2...Wall Street Logic | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | SponsoredNASA's ISS Replacement Could Go to This Tiny Space FirmNASA has commissioned SpaceX to decommission the $150 billion International Space Station, but the contract to...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetMed Express, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PetMed Express With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
